IDT and Elegen partner to launch an early access program offering long, clonal gene synthesis and high-complexity genes up to ...
6d
Zacks Investment Research on MSNPromising Genomics & Synthetic Biology Stocks to Consider in 2025Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary ...
16h
News-Medical.Net on MSN4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNAPLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well ...
Coralville-based Integrated DNA Technologies, a global leader in genomics solutions, has joined forces with Elegen, a leader in next-generation DNA ...
they had yet to provide any guidance that was specific to DNA synthesis companies or the recent advances in synthetic biology. In response to this gap, leaders in the nucleic acid synthesis industry ...
The ability to read and write bespoke segments of DNA is enabling unique solutions ... In June 2022, Vickers joined Eden Brew, a synthetic biology-driven food company, as its chief scientific ...
The two companies are collaborating to develop software tools to improve and simplify gene synthesis and biodesign. These tools will be used to optimize and automate Synplogen’s DNA synthesis ...
PLC ("4basebio" or the "Company") 4basebio Receives GMP Licence for its UK DNA Manufacturing Facility. Cambridge, UK, 2 April 2025 – 4basebio PLC (AIM: 4BB), an innovat ...
4basebio PLC has been granted Good Manufacturing Practice (GMP) certification by the UK’s Medicines and Healthcare products ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results